India Globalization Capital Appoints Former Congressman Jim Moran to its Board of Administrators
POTOMAC, Md.–(BUSINESS WIRE)–India Globalization Capital, Inc. (NYSE American: IGC) is pleased to announce that the Board of Directors has appointed former Congressman Jim Moran (“Congressman Moran”) as an independent director. IGC is pleased to welcome Congressman Moran to its Board of Directors.
Congressman Moran served 24 years in Virginia’s 8th congressional district, where he was known as a “problem solver.” Throughout his tenure, he demonstrated bipartisan leadership, working across the aisle to find common ground to solve complex problems. He has served on the Appropriation, Banking and Finance, and Budget committees. He played a leading role in defense, health and the environment.
During his 24 years in Congress, Congressman Moran has been recognized as a champion of innovative research and development in areas such as healthcare and national security, environmental protection and sustainability, and international trade and fiscal responsibility. He rose to leadership of the Appropriations Committee, which enabled him to bring billions of dollars to his northern Virginia communities of Alexandria, Arlington, and Fairfax Counties. Congressman Moran, who retired after 35 years in elected office, is now with a major law firm representing international and domestic clients in the areas of defense, technology, entertainment and international diplomacy. He also serves in leadership positions for several charitable foundations and is a member of the Government Blockchain Association.
Congressman Moran introduced the AUTISM Educators Act in 2012, which funded partnerships between public schools and colleges and nonprofit organizations to promote teaching skills for educators working with high-functioning autism students. He knows that treating and educating about conditions like autism and Alzheimer’s has the potential to positively impact millions of lives.
Congressman Moran received a master’s degree in public administration from the University of Pittsburgh Graduate School of Public and International Affairs and a bachelor’s degree in economics from the College of the Holy Cross.
With his extensive experience in Congress and as a policy advisor on issues such as health, technology and education, we are confident that Congressman Moran will be a great asset to IGC, especially as we begin Phase 2/3 trials on the People tracking IGC-AD1 to individuals who suffer from Alzheimer’s disease. We look forward to his guidance as he helps us bring new investigational THC-based drugs into FDA-approved clinical trials.
Upon his election to the IGC Board, Congressman Moran made the following statement: “I am pleased to have the opportunity to play a role in the growth of an organization dedicated to scientific and medical research with a particular focus on reduction dedicated to the pain and losses suffered from Alzheimer’s disease. While I’m aware of the medicinal benefits that marijuana may offer some people, IGC is involved in clinical research studies using cannabinoids from hemp to facilitate better brain function in individuals prone to Alzheimer’s. If such promising research is successful, it may have implications for advances in understanding other central nervous system diseases.”
India Globalization Capital, Inc. (IGC), headquartered in Maryland, is engaged in the development of cannabinoid-based therapies for healthcare applications. IGC recently completed the first clinical safety and tolerability study for the treatment of symptoms in Alzheimer’s patients with a new investigational THC-based drug. The company also operates an infrastructure business based in India. www.igcinc.us, www.igcpharma.com.